SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+25.03%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$434M
AUM Growth
+$434M
(+22%)
Cap. Flow
+$5.72M
Cap. Flow
% of AUM
1.32%
Top 10 Holdings %
Top 10 Hldgs %
35.56%
Holding
124
New
35
Increased
22
Reduced
19
Closed
17
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$16.2M |
| 2 |
Merck
MRK
|
$12.5M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$8.79M |
| 4 |
AstraZeneca
AZN
|
$6.57M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
$6.08M |
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
$49.8M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$9.12M |
| 3 |
GSK
GSK
|
$6.39M |
| 4 |
Gilead Sciences
GILD
|
$6.33M |
| 5 |
AGN
Allergan plc
AGN
|
$5.76M |
Sector Composition
| 1 | Healthcare | 81.27% |
| 2 | Technology | 6.25% |
| 3 | Communication Services | 1.95% |
| 4 | Industrials | 1.54% |
| 5 | Consumer Discretionary | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Merck
MRK
$210B
| $18.7M | 3.05% | 300,000 +200,000 | +200% | +$12.5M |
|
|
2
Teva Pharmaceuticals
TEVA
$21.1B
| $18.5M | 3.01% | 402,000 -198,200 | -33% | -$9.12M |
|
|
3
Sarepta Therapeutics
SRPT
$1.78B
| $16.2M | 2.63% | +263,047 | New | +$16.2M |
|
|
AGN
4
DELISTED
Allergan plc
AGN
| $16.1M | 2.62% | 70,000 -25,000 | -26% | -$5.76M |
|
5
Eli Lilly
LLY
$657B
| $16.1M | 2.61% | 200,000 | – | – |
|
6
Biogen
BIIB
$19.4B
| $15.7M | 2.55% | 50,000 -500 | -1% | -$157K |
|
|
CLCD
7
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| $15.3M | 2.48% | 400,000 -100,137 | -20% | -$3.82M |
|
8
Pfizer
PFE
$141B
| $14.4M | 2.35% | 426,612 | – | – |
|
9
Ituran Location and Control
ITRN
$671M
| $12.1M | 1.97% | 456,668 -3,784 | -0.8% | -$100K |
|
|
CELG
10
DELISTED
Celgene Corp
CELG
| $11.5M | 1.87% | 110,000 -45,000 | -29% | -$4.7M |
|
11
Amgen
AMGN
$155B
| $11M | 1.79% | 65,900 -19,100 | -22% | -$3.19M |
|
|
HZNP
12
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $9.7M | 1.58% | 535,000 +485,000 | +970% | +$8.79M |
|
|
13
Gilead Sciences
GILD
$140B
| $8.92M | 1.45% | 112,700 -80,000 | -42% | -$6.33M |
|
|
ALXN
14
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $8.58M | 1.4% | 70,000 +27,677 | +65% | +$3.39M |
|
15
Viatris
VTRS
$12.3B
| $7.62M | 1.24% | 200,000 -50,000 | -20% | -$1.91M |
|
|
SAGE
16
DELISTED
Sage Therapeutics
SAGE
| $7.35M | 1.2% | 159,500 +90,000 | +129% | +$4.14M |
|
17
Amicus Therapeutics
FOLD
$2.34B
| $6.7M | 1.09% | 905,000 -100,000 | -10% | -$740K |
|
|
18
AstraZeneca
AZN
$248B
| $6.57M | 1.07% | +200,000 | New | +$6.57M |
|
|
AKAO
19
DELISTED
Achaogen, Inc.
AKAO
| $6.23M | 1.01% | 1,300,313 +42,947 | +3% | +$206K |
|
|
ARRY
20
DELISTED
Array Biopharma Inc
ARRY
| $6.08M | 0.99% | +900,000 | New | +$6.08M |
|
21
Nice
NICE
$8.73B
| $5.76M | 0.94% | +86,040 | New | +$5.76M |
|
22
Corvus Pharmaceuticals
CRVS
$428M
| $5.35M | 0.87% | 325,053 | – | – |
|
23
Ascendis Pharma
ASND
$11.8B
| $5.3M | 0.86% | 263,500 +1,700 | +0.6% | +$34.2K |
|
|
CBIO
24
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
| $5.13M | 0.84% | 718,080 | – | – |
|
|
TSRO
25
DELISTED
TESARO, Inc.
TSRO
| $5.01M | 0.82% | +50,000 | New | +$5.01M |
|